Showing results (61-70 of 127) with videos related to
Sort By:
Pageof 13
Drugs Under Experimental and Clinical Research|January 1, 1987
Alterations in thyroid function induced by chronic administration of amiodaroneR Rumolo, E Vitolo, M Tronci, et al.Journal of Endocrinological Investigation|May 13, 2003
Effect of small doses of dexamethasone on plasma leptin levels in normal and obese subjects: a dose-response studyP Putignano, A Brunani, A Dubini, et al.Psychopharmacology|January 1, 1984
Inhibition by phospholipid liposomes of the prolactin and cortisol response to insulin hypoglycemia in manF Cavagnini, C Maraschini, A Dubini, et al.The Journal of Clinical Endocrinology and Metabolism|July 1, 1975
Inhibition of ACTH response to oral and intravenous metyrapone by antiserotoninergic treatment in manF Cavagnini, A E Panerai, F Valentini, et al.European Journal of Endocrinology|May 2, 2001
Inferior petrosal sinus sampling in the differential diagnosis of Cushing's syndrome: results of an Italian multicenter studyA Colao, A Faggiano, R Pivonello, et al.Journal of Endocrinological Investigation|September 1, 1991
Four year treatment with a long acting somatostatin analogue in a patient with Verner-Morrison syndromeA Brunani, C Crespi, M De Martin, et al.Blood Pressure. Supplement|January 1, 1996
Obesity and the sympathetic nervous systemG Grassi, B M Cattaneo, G Seravalle, et al.The Journal of Endocrinology|May 30, 2003
Corticotrophin-releasing activity of desmopressin in Cushing's disease: lack of correlation between in vivo and in vitro responsivenessF Pecori Giraldi, E Marini, E Torchiana, et al.Journal of Endocrinological Investigation|June 20, 1998
Plasma somatostatin-like immunoreactivity and somatostatin-28 levels in obese menM Peracchi, F Carola, F Cavagnini, et al.International Journal of Obesity (2005)|June 28, 2007
Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjectsL Alberti, A Girola, L Gilardini, et al.Pageof 13